` FLGT (Fulgent Genetics Inc) vs S&P 500 Comparison - Alpha Spread

FLGT
vs
S&P 500

Over the past 12 months, FLGT has underperformed S&P 500, delivering a return of -5% compared to the S&P 500's 10% growth.

Stocks Performance
FLGT vs S&P 500

Loading
FLGT
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
FLGT vs S&P 500

Loading
FLGT
S&P 500
Difference
www.alphaspread.com

Performance By Year
FLGT vs S&P 500

Loading
FLGT
S&P 500
Add Stock

Competitors Performance
Fulgent Genetics Inc vs Peers

Fulgent Genetics Inc
Glance View

Market Cap
598m USD
Industry
Health Care

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

FLGT Intrinsic Value
10.59 USD
Overvaluation 46%
Intrinsic Value
Price
Back to Top